Stock Earnings

Question 1

What are CERo Therapeutics Holdings, Inc.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), CERo Therapeutics Holdings, Inc. has a total asset of $234, Net profit of $2

Question 2

What are the key financial ratios for CEROW?

Accepted Answer

CERo Therapeutics Holdings, Inc.'s Current ratio is 26, has a Net margin is 0, sales per share of $0.

Question 3

How is CERo Therapeutics Holdings, Inc.'s revenue broken down by segment or geography?

Accepted Answer

CERo Therapeutics Holdings, Inc. largest revenue segment is Cannabis, at a revenue of 671,545 in the most earnings release.For geography, United States is the primary market for CERo Therapeutics Holdings, Inc., at a revenue of 671,545.

Question 4

Is CERo Therapeutics Holdings, Inc. profitable?

Accepted Answer

yes, according to the latest financial statements, CERo Therapeutics Holdings, Inc. has a net profit of $2

Question 5

Does CERo Therapeutics Holdings, Inc. have any liabilities?

Accepted Answer

yes, CERo Therapeutics Holdings, Inc. has liability of 9

Question 6

How many outstanding shares for CERo Therapeutics Holdings, Inc.?

Accepted Answer

CERo Therapeutics Holdings, Inc. has a total outstanding shares of 31.62

CERo Therapeutics Holdings, Inc. (CEROW) Price

CEROW Stock Price Chart

Follow-Up Questions

What are CERo Therapeutics Holdings, Inc.'s key financial statements?

What are the key financial ratios for CEROW?

How is CERo Therapeutics Holdings, Inc.'s revenue broken down by segment or geography?

Is CERo Therapeutics Holdings, Inc. profitable?

Does CERo Therapeutics Holdings, Inc. have any liabilities?

How many outstanding shares for CERo Therapeutics Holdings, Inc.?

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

EPS (TTM)

Dividend yield

Market Cap

What is CERo Therapeutics Holdings, Inc?